Cargando…

Hepatitis B vaccination coverage in Germany: systematic review

BACKGROUND: Despite being considered as a low prevalence country for hepatitis B (HBV), some populations in Germany are at higher risk of infection. In the context of the World Health Organization’s (WHO) viral hepatitis elimination goals, a valid epidemiological data base is needed to plan and moni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steffen, Gyde, Sperle, Ida, Harder, Thomas, Sarma, Navina, Beermann, Sandra, Thamm, Roma, Bremer, Viviane, Zimmermann, Ruth, Dudareva, Sandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364709/ https://www.ncbi.nlm.nih.gov/pubmed/34391406 http://dx.doi.org/10.1186/s12879-021-06400-4

Ejemplares similares

The epidemiology of Hepatitis B, C and D in Germany: A scoping review
por: Steffen, Gyde, et al.
Publicado: (2020)

Prevalence of Hepatitis B, C, and D in Germany: Results From a Scoping Review
por: Sperle, Ida, et al.
Publicado: (2020)

Wie lässt sich die Eliminierung von Hepatitis B, C und D in Deutschland messen? Ergebnisse eines interdisziplinären Arbeitstreffens
por: Zimmermann, Ruth, et al.
Publicado: (2020)

Epidemiologie der Virushepatitiden A bis E in Deutschland
por: Dudareva, Sandra, et al.
Publicado: (2022)

Viral hepatitis in Germany: poor vaccination coverage and little knowledge about transmission in target groups
por: Schenkel, Karl, et al.
Publicado: (2008)

Hepatitis-B-Virus-Infektionen und impfinduzierte Immunität: die Rolle von soziodemografischen Determinanten: Ergebnisse der „Studie zur Gesundheit Erwachsener in Deutschland“ (DEGS1, 2008–2011)
por: Brodzinski, Annika, et al.
Publicado: (2021)

Markedly decreasing azithromycin susceptibility of Neisseria gonorrhoeae, Germany, 2014 to 2021
por: Selb, Regina, et al.
Publicado: (2021)

Not again! Effect of previous test results, age group and reason for testing on (re-)infection with Chlamydia trachomatis in Germany
por: Lang, Alexandra Sarah, et al.
Publicado: (2018)

High variability of TB, HIV, hepatitis C treatment and opioid substitution therapy among prisoners in Germany
por: Müller, Jana, et al.
Publicado: (2017)

Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance
por: Buder, Susanne, et al.
Publicado: (2018)

Establishment of a voluntary electronic Chlamydia trachomatis laboratory surveillance system in Germany, 2008 to 2014
por: Dudareva-Vizule, Sandra, et al.
Publicado: (2017)

COVID-19 Outbreaks in Settings With Precarious Housing Conditions in Germany: Challenges and Lessons Learned
por: Zimmermann, Ruth, et al.
Publicado: (2021)

Prevalence of Chlamydia trachomatis in the general population in Germany – a triangulation of data from two population-based health surveys and a laboratory sentinel system
por: Gassowski, Martyna, et al.
Publicado: (2022)

Additional challenges in reaching hepatitis C elimination goals in Germany due to the COVID-19 pandemic - descriptive analysis of drug prescription data from January 2018 to June 2021
por: Meyer, Emily D., et al.
Publicado: (2023)

STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in Germany
por: Jansen, Klaus, et al.
Publicado: (2020)

12-Month prevalence of allergies in Germany
por: Schmitz, Roma, et al.
Publicado: (2017)

COVID-19 cross-border case and contact tracing activities - experiences and lessons learnt, Germany, April-December 2020
por: Sperle, Ida, et al.
Publicado: (2023)

Implications of a change in case definition and screening of asylum seekers for hepatitis B surveillance in Germany in 2015 and 2016
por: von Laer, A., et al.
Publicado: (2020)

Prevalence of hepatitis C in the adult population of Bulgaria: a pilot study
por: Sperle, Ida, et al.
Publicado: (2020)

A shift from travel-associated cases to autochthonous transmission with Berlin as epicentre of the monkeypox outbreak in Germany, May to June 2022
por: Selb, Regina, et al.
Publicado: (2022)

Allergic rhinitis and asthma among children and adolescents in Germany. Results of the cross-sectional KiGGS Wave 2 study and trends
por: Poethko-Müller, Christina, et al.
Publicado: (2018)

Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008–2019
por: Maisa, Anna, et al.
Publicado: (2021)

Allergic diseases in children and adolescents in Germany. Results of the cross-sectional KiGGS Wave 2 study and trends
por: Thamm, Roma, et al.
Publicado: (2018)

High prevalence of hepatitis C virus infection and low level of awareness among people who recently started injecting drugs in a cross-sectional study in Germany, 2011–2014: missed opportunities for hepatitis C testing
por: Enkelmann, Julia, et al.
Publicado: (2020)

Corrigendum: Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008–2019
por: Maisa, Anna, et al.
Publicado: (2022)

Decreasing seroprevalence of herpes simplex virus type 1 and type 2 in Germany leaves many people susceptible to genital infection: time to raise awareness and enhance control
por: Korr, Gerit, et al.
Publicado: (2017)

Developing and Piloting a Standardized European Protocol for Hepatitis C Prevalence Surveys in the General Population (2016–2019)
por: Sperle, Ida, et al.
Publicado: (2021)

Are the testing needs of key European populations affected by hepatitis B and hepatitis C being addressed? A scoping review of testing studies in Europe
por: Lazarus, Jeffrey V, et al.
Publicado: (2016)

Concordance between self-reported and measured HIV and hepatitis C virus infection status among people who inject drugs in Germany
por: Nielsen, Stine, et al.
Publicado: (2016)

A dynamic transmission model to calculate vaccination coverage needed to control COVID-19 in Germany
por: Waize, M, et al.
Publicado: (2022)

Hepatitis E Virus Seroprevalence among Adults, Germany
por: Faber, Mirko S., et al.
Publicado: (2012)

High hepatitis B vaccination coverage among a cohort of predominantly men who have sex with men in Germany
por: Esber, Allahna L., et al.
Publicado: (2023)

Prevalence of hepatitis B and C, HIV, and syphilis among people who inject drugs in Germany
por: Steffen, G, et al.
Publicado: (2022)

A systematic review of Hepatitis C virus treatment uptake among people who inject drugs in the European Region
por: Lazarus, Jeffrey V, et al.
Publicado: (2014)

Lymphogranuloma Venereum in Men Screened for Pharyngeal and Rectal Infection, Germany
por: Haar, Karin, et al.
Publicado: (2013)

Slurry Tales: Newspaper Coverage of Livestock Slurry Reproduces Public Discourse on Agriculture in Germany
por: Artner-Nehls, Astrid, et al.
Publicado: (2023)

Vaccine coverage and factors associated with vaccine adherence in persons with HIV at an urban infectious disease clinic
por: Birk, Navina K., et al.
Publicado: (2023)

Varicella vaccination coverage of children under two years of age in Germany
por: Reuss, Annicka M, et al.
Publicado: (2010)

Molecular epidemiological typing of Neisseria gonorrhoeae isolates identifies a novel association between genogroup G10557 (G7072) and decreased susceptibility to cefixime, Germany, 2014 to 2017
por: Banhart, Sebastian, et al.
Publicado: (2020)

Social inequalities in health of children and adolescents in Germany. Results of the cross-sectional KiGGS Wave 2 study
por: Kuntz, Benjamin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_m27585ovvarftb8b2ejcm4lt6v